They indicate that VEGF-B has anti-apoptotic effects and is beneficial in cardiovascular disease and neuroprotective in the setting of cerebral ischemia and animal models of Amyotrophic Lateral Sclerosis and Parkinson’s disease. This evidence concerns the gene VEGFB and brain ischemia.